Home > Insider Trading > Filing (0001683168-19-002124)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516079	Us-China Biomedical Technology Inc.	UCBB	Services-Advertising Agencies (7311)	274479356

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1713489	Qingxi Huang	21F, Hualing Building 111 Furong Rd, Changsha Hunan Province, China F4 410000	Ceo, Cfo, Secy., Treas.	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-29	4,290,000	$214,500.00	12,422,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2019-05-29	10,725,000	$0.05	10,725,000	$0.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,725,000	2019-05-24	2020-11-24	No	4	P	Indirect

Footnotes

On May 29, 2019, China Israel Biotechnology Co. Ltd. ("CIB"), a Chinese corporation, of which Mr. Huang is a controlling officer and director of, acquired 4,290,000 units at purchase price of $0.05 per share. Each single Unit consists of one (1) share of common stock of the Company and two and one half (2.5) warrants (collectively the "Units"), which shall be exercisable for 18 months at $0.05 per share (the "Warrants").
Mr. Huangs beneficial ownership includes 10,922,000 shares held by CIB and 1,500,000 shares held by Central Bio-MD Valley Technology Co., Ltd. ("CBV"), a Chinese corporation. Mr. Huang is a controlling officer and director of CIB and CBV and has voting and dispositive control over the shares.